Activated extracellular signal-regulated kinase correlates with cyst formation and transforming growth factor-β expression in fetal obstructive uropathy  by Omori, S. et al.
Activated extracellular signal-regulated kinase
correlates with cyst formation and transforming
growth factor-b expression in fetal obstructive
uropathy
S Omori1,2, H Kitagawa3, J Koike4, H Fujita1, M Hida1, KC Pringle5 and M Awazu1
1Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan; 2Department of Pediatrics, Saitama Municipal Hospital
Perinatal Center, Saitama, Japan; 3Division of Pediatric Surgery, St Marianna University School of Medicine, Kawasaki, Japan;
4Department of Pathology, St Marianna University School of Medicine, Kawasaki, Japan and 5Department of Obstetrics and
Gynecology, School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand
Human renal dysplasia is frequently associated with urinary
tract obstruction and the abnormal expression of mitogen-
activated protein kinase (MAPK). Here, we determined the
renal responses and MAPK expression in developing kidneys
that were obstructed in fetal lambs. Kidneys were harvested
at various times after obstruction (gestation day 60) through
normal term (day 145). Dilation of Bowman’s capsule and
proximal tubules was seen 2 days after obstruction and
involved the whole cortex 18 days later, with numerous cysts
present throughout the kidney at term. The proliferation
marker Ki-67 and transforming growth factor-b (TGF-b) were
detected 2 days after obstruction and progressively increased
in tubules, cysts, and the interstitium. In control kidneys, p38
was expressed in tubules only during the fetal stage, whereas
phosphorylated extracellular signal-regulated kinase (P-ERK)
was limited to ureteric buds and collecting ducts at all stages
examined. However, Jun-N-terminal kinase (JNK) was absent
in the fetal kidney but present in tubules at term. In
obstructed kidneys, cyst epithelia were positive for p38 and
P-ERK but negative for JNK throughout all stages. These
studies show that P-ERK correlated spatially and temporally
with Ki-67 and TGF-b expression, which suggests that ERK
may contribute to cyst formation and fibrosis in the
obstructed fetal kidney.
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Mitogen-activated protein kinases (MAPKs) are enzymes that
have important functions in various cellular functions
including proliferation, differentiation, and apoptosis.
We previously reported that MAPKs are developmentally
regulated in the rat kidney.1 Thus, extracellular signal-
regulated kinase (ERK) and p38 MAPK (p38) are strongly
expressed in the fetal kidney, whereas c-Jun N-terminal
kinase (JNK) is detected predominantly in the adult kidney.
The inhibition of ERK or p38 by specific inhibitors in
organ-cultured kidneys resulted in disturbed nephron
formation, ureteric bud growth, and kidney growth,
demonstrating important roles of MAPKs in renal develop-
ment.2 Furthermore, a persistent fetal expression pattern of
MAPKs was observed in cyst epithelium of human renal
dysplasia, suggesting that dysregulated MAPKs may lead to
kidney malformation.3
Renal dysplasia is one of the commonest kidney
malformations that lead to chronic renal failure in children.4
It is characterized by dysplastic tubules connected to cysts
and surrounding undifferentiated tissues. Collars of fibro-
muscular-like cells are often found surrounding and closely
applied to these dysplastic tubules. Obstruction of the
urinary tract often accompanies dysplastic kidneys, and is
suggested to be one of the etiologic factors. In animal
experiments, prenatal obstruction of the urinary tract
reproduces dysplastic changes similar to human renal
dysplasia.5,6 In an ovine model, the timing of obstruction
determines the phenotype of kidneys. Obstruction at
gestational ages 50–60 days produces a dysplastic kidney,
whereas obstruction more than 90 days of gestation generates
hydronephrosis with no cysts or disorganized architecture.5
The site of obstruction also affects the kidney phenotype.
Thus, urethral and urachal ligation at 50 days or ureteral
ligation at 60 days generates hypoplastic kidneys with cysts,
whereas urethral and urachal ligation at 60 days produce
large cystic kidneys similar to human multicystic kidneys.7 It
was hypothesized that the effect of the increased pressure
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transmitted to the kidney was delayed in urethral ligation
because it took some time for the bladder to decompensate,
compared with the immediate effect of ureteric ligation.
In an adult animal model, urinary tract obstruction leads
to proliferation of tubule epithelial cells and interstitial
fibrosis, and the expression of activated ERK closely
correlated with these events, both temporally and spatially.8,9
In a similar manner to an adult animal model, increased
undifferentiated mesenchyme and fibromuscular collars were
observed in fetal urinary tract obstruction, which was
accompanied by increased expression of transforming growth
factor-b (TGF-b), extracellular matrixes, and a-smooth
muscle actin (aSMA).10,11 Dysregulated MAPK expression,
that is, increased ERK and p38 expression was also found in
undifferentiated mesenchyme of human renal dysplasia,
suggesting their role in fibrosis as well as in cyst formation.3
In this study, we sequentially investigated the expression of
MAPKs and molecules related to cyst formation and fibrosis
after fetal urinary tract obstruction.
RESULTS
Cyst formation and Pax2 expression
Dilation of Bowman’s capsule and proximal tubules identi-
fied by CD10 staining was observed in the nephrogenic zone
48 h after obstruction (embryonic day 62 (E62); data not
shown). Changes compatible with tubular necrosis were also
observed that are subsided by E67. This probably reflects
ischemic changes by obstruction.12,13 Cysts were found
mainly in the cortex at E67 (Figure 1a and b), expanding
to the whole cortex by E80 (data not shown). Numerous cysts
are present throughout the kidney at neonatal day 1 (N1)
(Figure 1c). Transcription factor Pax2 was expressed in
ureteric buds, nephron precursors, and primitive proximal
tubules of normal kidneys at E60 (Figure 1d). The expression
decreased as the kidney matured and was limited to collecting
ducts at N1 (Figure 1e). In obstructed kidneys, Pax2
expression persisted up to N1 localizing in tubule and cyst
epithelial cells (Figure 1f).
Proliferation and apoptosis in cyst epithelium and the
interstitium
In normal fetal kidneys, Ki-67-positive cells were present in
the nephrogenic zone immediately under the renal capsule
(Figure 2a). Occasional cells in glomerular precursors and
ureteric bud tips expressed Ki-67. In obstructed kidneys at
E62–E80, Ki-67-positive cells were also recognized in dilated
Bowman’s capsules and tubules, cysts, and occasionally in the
interstitium (Figure 2b). Ki-67 expression progressively
increased toward N1 (Figure 2c).
In normal kidneys, TUNEL (terminal deoxynucleotide
transferase-mediated nick-end labeling) staining was not
detectable at any stage examined (Figure 2d). In obstructed
kidneys, apoptotic cells were detected in the urothelium at
E62–E67 (data not shown), in the inner medulla at E80
(Figure 2e), and throughout the kidney in tubules, cysts, and
surrounding interstitial cells at N1 (Figure 2f).
Tubulointerstitial changes after intrauterine urinary tract
obstruction
Transforming growth factor-b was rarely detected in control
kidneys at any stage examined (Figure 3a). In the obstructed
kidney, TGF-b was recognized in dilated tubule epithelial
cells and occasionally in the interstitium as early as 48 h after
obstruction (Figure 3b). TGF-b expression became intense
as gestational age increased (Figure 3c). Glomerular cyst
epithelial cells were also occasionally TGF-b-positive. In
control kidneys, aSMA was detected only in arterial smooth
muscle cells and mesangial cells (Figure 3d). In obstructed
kidneys, aSMA was expressed in the interstitium at 48 h after
obstruction and increased as pregnancy progressed (Figure 3e
and f). aSMA was not detected in tubule cells or glomerular
precursors.
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Figure 1 | Distribution of cysts and Pax2 expression in kidneys
with intrauterine urinary tract obstruction (original
magnification  100 unless otherwise indicated). Kidneys were
harvested at embryonic day 67 (E67, a, b) or neonatal day 1
(N1, c) from lambs with intrauterine urinary tract obstruction (Ob)
at E60. (a) Dilation of Bowman’s capsule (arrows) and proximal
tubules identified by CD10 staining was observed predominantly
in the cortex. (b) In the medulla, dilation of distal segments is
occasionally observed. (c) Numerous cysts derived from proximal
and distal segments are present throughout the kidney at N1.
In the normal control kidney (Con), Pax2 is expressed in
glomerular precursors (arrows), ureteric buds (arrowheads), and
occasionally in primitive proximal tubules at E60 (d, original
magnification  200). (e) At N1, the expression is limited to collecting
ducts (arrows). (f) In the obstructed kidney at N1, intense Pax2
staining is observed in cysts and tubules.
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Persistent fetal expression pattern of p38 and JNK in cyst
epithelium
In normal kidneys, p38 was expressed in tubules during the
fetal stage (Figure 4a), but no longer detected at N1 (Figure 4b).
In contrast, p38 were intensely stained in tubule and cyst
epithelium throughout all stages in obstructed kidneys
(Figure 4c). The interstitial cells of obstructed kidneys were
also occasionally positive for p38 at E81 (data not shown)
and exclusively positive at N1 (Figure 4c).
Contrary to p38, JNK was not expressed in the normal
fetal kidney (Figure 3d) and became positive in tubules and
podocytes at N1 (Figure 3e). In contrast, JNK was not
detected in tubule or cyst epithelium of obstructed kidneys at
N1 (Figure 4f).
Expression of P-ERK correlates with cyst formation and TGF-b
expression
In control kidneys, phosphorylated-ERK (P-ERK) expression was
limited to ureteric buds and collecting ducts at any stage
examined (Figure 5a). In obstructed kidneys, P-ERK was detected
in collecting ducts and to a lesser extent in dilated tubules at
E62 (Figure 5b). Occasional epithelial cells in dilated Bowman’s
capsule were also positive for P-ERK. The expression gradually
increased in tubules and cysts and also in the interstitium
(Figure 5c and d). Both temporal and spatial expressions of
P-ERK were closely correlated with that of Ki-67 and TGF-b.
ERK was expressed in tubules and podocytes throughout all
stages in normal kidneys (Figure 5e). In obstructed kidneys, ERK
was also detected in cysts and the interstitium (Figure 5f).
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Figure 2 | Distribution of proliferating cells and apoptosis in
normal kidneys and kidneys with intrauterine urinary tract
obstruction (original magnification  100 unless otherwise
indicated). In the normal kidney (Con) at E60, Ki-67 expression is
observed in the nephrogenic zone (a, original magnification  200).
Cells in condensing mesenchyme, vesicles, S-shaped bodies, and
tips of ureteric bud branches are occasionally stained (arrows).
(b) In the obstructed kidney (Ob) at E65, nephrogenic zone is
compressed, and dilated tubules, Bowman’s capsule epithelial cells,
surrounding interstitial cells, and podocytes are positive for Ki-67.
At N1, Ki-67 expression is observed in tubules, cysts (arrows),
and occasional interstitial cells (arrowheads) (c, original magnification
 200). (d–f) Labeling of apoptotic cells using TUNEL assay.
In the obstructed kidney at E81, positive staining is found in
collecting duct cells and occasional interstitial cells of the medulla
(e, original magnification  200) but not detected in the cortex
(d, original magnification  200). (f) At N1, apoptotic cells are
numerous in the interstitium and also observed in cysts.
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Figure 3 | Immunohistochemical localization of TGF-b and
aSMA in normal kidneys and kidneys with intrauterine urinary
tract obstruction (original magnification  100). TGF-b is not
expressed in the normal control kidney (Con) (E80, a). (b) In the
obstructed kidney (Ob), TGF-b immunostaining is recognized in
tubule cells and occasional Bowman’s capsule cells as early as 48 h
after obstruction. Tubular dilatation and sloughing of epithelial
cells, classic changes of acute tubular necrosis, are also observed.
(c) At E80, TGF-b expression expands and is recognized in cysts,
tubules, and the interstitium. The normal kidney expresses aSMA
only in vascular smooth muscle cells (arrowheads) and mesangial
cells (arrows) (E80, d). (e) The obstructed kidney at E62 shows
periglomerular and peritubular expressions of aSMA. aSMA
expression increases in the interstitium and fibromuscular collars
as gestational age increases (E80, f).
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Results for the immunohistochemistry data are summarized
in Table 1.
DISCUSSION
This study shows that expression of MAPKs is dysregulated
in obstructive uropathy in fetal lambs. p38 and ERK, which
mediate proliferation, are upregulated or activated, and JNK
is downregulated in tubule and cyst epithelial cells of
obstructed kidneys. The abnormal expression of MAPKs is
associated with increased expression of Ki-67 and Pax2,
suggesting that dysregulated MAPKs may mediate hyperpro-
liferation of epithelial cells, leading to cyst formation. The
activated form of ERK, P-ERK, was also found in the
interstitium, and temporal and spatial expression of P-ERK
correlated with that of TGF-b, suggesting it has a role in
fibrosis as well.
We previously reported that p38 was expressed in the
developing rat kidney.1 The expression of p38 was localized
in uninduced mesenchyme, condensing mesenchyme, and
ureteric buds. p38 was detected up to postnatal day 1 when
tubules were also stained. In normal ovine kidneys at E81,
p38 was already detected in tubules. The reason for the
discrepancy is probably because rat and ovine kidneys
develop over a different time frame. In sheep, nephrogenesis
ceases by day 130, whereas nephron formation continues up
to postnatal day 8 in rats. In the neonatal ovine kidney, p38
was no longer expressed. In obstructed ovine kidneys, p38
was expressed in tubules and cysts, as well as in interstitial
cells at N1. Although p38 was classically thought to
mediate apoptosis, we previously showed that its expression
correlated with proliferation rather than apoptosis in
the developing kidney.1 Furthermore, the p38 inhibitor
SB203580 suppressed metanephros growth in organ culture.2
It is now widely known that the function of p38 relates not
only to apoptosis and stress response but also to proliferation
and differentiation in many cell types.14
In contrast to p38, ERK is expressed throughout
development up to adulthood in the rat, with highest
expression and activation levels in the fetal kidney.1 At an
early stage, ERK localizes in the nephrogenic zone and shifts
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Figure 4 | Immunohistochemical localization of p38 and JNK in
normal kidneys and kidneys with intrauterine urinary tract
obstruction (original magnification  100 unless otherwise
indicated). In the normal kidney (Con), p38 is expressed in tubules
at E81 (a), but no longer detected at N1 (b). In the obstructed kidney
(Ob), the expression persists into N1, and is recognized in cysts,
tubules, and the interstitium (c). (e) JNK, however, is not expressed
in the normal kidney at E81 (d, original magnification  200),
but is recognized in tubules and podocytes at N1. (f) The
obstructed kidney is negative for JNK at N1.
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Figure 5 | Immunohistochemical localization of P-ERK and ERK in
normal kidneys and kidneys with intra-uterine urinary tract
obstruction (original magnification  100). In the normal kidneys
(Con), P-ERK expression is limited to ureteric buds and collecting
ducts (N1, a, arrows). (b) In the obstructed kidney (Ob) at E62,
P-ERK is also detected in dilated tubules (arrows) and weakly in
Bowman’s capsule cells (arrowheads). The expression gradually
increases in tubules and cysts and also in the interstitium (E80,
c; N1, d). ERK is expressed in tubules and podocytes throughout
all stages in normal kidneys (N1, e), and also in cysts and the
interstitium in the obstructed kidney (N1, f).
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to the deep cortex and the medulla corresponding to tubule
maturation.1 In the normal ovine fetal kidney examined in
this study, ERK was expressed in all tubular segments, in a
similar manner to rat neonatal kidney, probably reflecting the
later developmental stage. The expression of P-ERK corre-
lated with that of ERK in the rat kidney, whereas P-ERK was
restricted to ureteric buds and collecting ducts in the normal
ovine kidney. This may be ascribed to different species but
also to the different antibodies used. In this study, we used
monoclonal antibody, which gives less nonspecific staining.
In the obstructed ovine kidney, dilated tubules became
positive for P-ERK as early as 48 h after obstruction. The
expression of P-ERK increased in tubule and cyst epithelial
cells, and also in the interstitium as gestational age increased.
Increased P-ERK, in addition to p38, in tubule and cyst
epithelial cells of obstructed kidneys may mediate high-rate
cell turnover and the maintenance of undifferentiated states.
We previously reported that JNK was expressed predomi-
nantly in tubules of the adult rat kidney.1 Thus, JNK may be
involved in the differentiation at a later stage or the
maintenance of the integrity of tubule epithelial cells. In
support of the prior possibility, JNK has recently been shown
to mediate mesenchymal–epithelial transformation in an
organ culture study.15 In this study, JNK was not expressed in
normal ovine kidneys up to E92 but was detected in the
neonatal kidney. In contrast, tubule and cyst epithelial cells
were completely negative for JNK in obstructed kidneys. The
lack of JNK may be either the cause or the result of the
undifferentiated state of epithelial cells.
The abnormal patterns of MAPK expression in cysts
of fetal obstructed kidney is similar to that seen in cysts of
human dysplastic kidney and of a murine model of polycystic
kidney disease DBA/2-pcy/pcy (pcy) mice.3,16 Polycystic
kidney disease is characterized by the progressive expansion
of multiple cysts that exhibit similar features to those of
dysplasia, that is, increased proliferation, apoptosis, and
expression of a transcription factor Pax2.17,18 We recently
reported that the expression of MAPKs is dysregulated in a
similar manner to human dysplastic kidney in pcy mice.16
Administration of an inhibitor of upstream activator of ERK,
MEK, in pcy mice inhibited cyst formation and improved
renal function. These findings demonstrate the role of ERK in
cyst formation in polycystic kidney disease, and the same
mechanisms may be operative in renal dysplasia.
Winyard and Attar17–19 demonstrated that epithelial cells
of human dysplastic kidneys, polycystic kidneys, and fetal
ovine obstructed kidneys maintain a high rate of prolifera-
tion along with the expression of Pax2. Whereas excessive
Pax2 results in cystic diseases, the reduced Pax2 gene dosage
reduced cyst formation in cpk mice, a murine model of rapid-
onset polycystic kidney disease.20,21 Pax2 is thought to be
necessary for prevention of apoptosis.22 The expression of
p38 and P-ERK correlate with those of Pax2 in human renal
dysplasia, murine polycystic kidney disease, and the present
intrauterine urinary tract obstruction.3,16,18 The components
of the Pax2-mediated pathway are not well defined. It is
conceivable that p38 and ERK are involved in signaling events
upstream or downstream of Pax2.
What are the causes of dysregulated MAPKs in cyst
epithelium in the obstructed kidney? Of interest, ERK has
been shown to be activated by cell stretch in many cell types.23
It is possible that urinary tract obstruction may activate ERK or
p38 by epithelial cell stretch causing proliferation, apoptosis,
and epithelial–mesenchymal transformation leading to the
evolution of dysplastic kidneys. In our preliminary study, cyclic
stretch of ureteric bud cells activates ERK and p38. Other
investigators have reported that cyclic stretch of renal epithelial
cells causes apoptosis and TGF-b expression.24,25
Transforming growth factor-b is a molecule implicated in
epithelial–mesenchymal transformation in various tissues.
Yang et al.10,11 demonstrated that TGF-b is upregulated in the
epithelium of human renal dysplasia and ovine intrauterine
ureteric obstruction and suggested that TGF-b might be
responsible for the pathobiology of dysplastic kidneys.
Miyajima et al.25 also reported that TGF-b mediates tubular
apoptosis and fibrosis in unilateral ureteral obstruction.
Notably, ERK and p38 have been shown to mediate TGF-b
production stimulated by cell stretch in mesangial cells or by
high glucose in proximal tubule cells.26,27 Thus, TGF-b
upregulation in urinary tract obstruction may be mediated by
ERK or p38. The temporospatial expression of P-ERK and, to
a lesser extent, of p38, correlated with TGF-b expression. It is
also conceivable that ERK and p38 may mediate apoptotic
and profibrotic effects of TGF-b in obstructive kidneys, as
ERK and p38 are known to be downstream of TGF-b
Table 1 | Proliferation, apoptosis, and expression of TGF-b
and MAPKs in normal kidneys and kidneys with intrauterine
urinary tract obstruction
Ki-67 TUNEL TGF-b P-ERK p38 JNK
E80
Con
UB +(tip)   +  
Tubules     + 
Interstitium      
Ob
Tubules +  + + ++ 
CD + +(inner medulla) + ++ ++ 
Cysts + +(inner medulla) ++ + ++ 
Interstitium + +(inner medulla) + + + 
N1
Con
Tubules      +
CD    +  +
Ob
Tubules/cysts + + ++ ++ ++ 
Interstitium + + + + + 
CD, collecting ducts; Con, normal control kidneys; E80, embryonic day 80; JNK, c-Jun
N-terminal kinase; MAPKs, mitogen-activated protein kinases; N1, neonatal day 1;
Ob, obstructed kidneys; p38, p38 MAP kinase; P-ERK, phosphorylated extracellular
signal-regulated kinase; TUNEL, terminal deoxynucleotide transferase-mediated
nick-end labeling; UB, ureteric buds.
(), no immunoreactivity; (+ to ++), increasing intensity and percentage of staining
present in the designated cell population unless otherwise specified.
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signaling in several cellular functions. In support of this
possibility, an in vitro study by Dai et al.28 showed that TGF-
b1 signaling potentiates renal tubular epithelial cell apoptosis
by a p38-dependent mechanism. Also, TGF-b1-induced
epithelial–mesenchymal transformation was shown to be
mediated by ERK and p38 in NRK-52E cells.29
In contrast to ERK and p38, JNK has been shown to
suppress the expression of TGF-b in fibroblasts.30 Thus, the
absence of JNK in cyst epithelial cells in fetal obstructive
uropathy, human dysplasia, and murine polycystic kidney
may have a role in epithelial–mesenchymal transformation. In
our preliminary study, blockade of JNK in inner medullary
collecting duct cells increased TGF-b expression and
decreased E-cadherin expression, supporting this hypothesis.
We examined the sequential changes after intrauterine
urinary tract obstruction at an early developmental stage.
Dilation of nephron segments started in Bowman’s capsule
and proximal tubules immediately after obstruction, and
extended to the whole segments by birth. In the previous
study by Cachat et al.31 in neonatal mice, dilation started in
the collecting tubules. However, intrauterine obstruction in
sheep at E80, a later gestational age than this study, affected
the proximal nephron rather than the collecting ducts.32
Thus, when Mure et al. created urinary tract obstruction in
fetal lambs at 90 days of gestation, neither cysts nor dysplasia
was observed, although cystic-dilated glomeruli and dilated
tubules throughout the cortex were noted. Shibata et al.33
reported that cyst formation begins predominantly in the
subcapsular nephrogenic zone in human renal dysplasia with
or without obstruction. Three-dimensional analysis of
nephrons showed that glomerular cysts were the first cysts
in the nephron, suggesting that fluid retention occurs at the
site of active filtration. In the fetal rhesus monkey,
obstruction at 70–90 days of gestation (term 165 days of
gestation) induced dysplasia; glomerular cysts were also
observed.6 Taken together, these findings suggest that in utero
urinary tract obstruction at an early stage may result in cyst
formation in the nephrogenic zone, disturbing the subse-
quent nephrogenesis resulting in dysplasia.
In conclusion, the dysregulated MAPK may play a role in
cyst formation and fibrosis in intrauterine obstruction. As
pharmacological inhibition of ERK or p38 is possible, our
study may allow development of novel therapeutic strategies
for renal dysplasia. The cause of the activation and upregula-
tion of ERK and p38, and downregulation of JNK, may be
the mechanical stretch of epithelial cells due to obstruction.
In vitro studies are underway to prove this hypothesis.
MATERIALS AND METHODS
Experimental animals
Approval was obtained from the Wellington School of Medicine and
Health Sciences Animal Ethics Committee. Fetal lambs were
operated on 60 days of gestation (n¼ 48). Male lambs had their
penile urethra and urachus ligated and female lambs had their
bladder neck and urachus ligated. The lambs were delivered by
cesarean section 48 h (n¼ 4), 3 days (n¼ 4), 5 days (n¼ 2), 7 days
(n¼ 5), 20–31 days later (n¼ 29), or at term (145 days of gestation,
n¼ 4), as reported previously.12,34 Kidneys from sham-operated and
unoperated lambs served as controls (E60, n¼ 3; E80–E92, n¼ 11;
N1, n¼ 4). Kidneys were harvested and fixed with neutral-buffered
formalin and embedded in paraffin.
Reagents
Anti-CD10 antibody was from Novocastra Laboratories (Newcastle,
UK). Rabbit anti-Pax2 antibody was from Zymed Laboratories
(South San Francisco, CA, USA). Mouse anti-human Ki-67 antibody
was from BD Biosciences (San Jose, CA, USA). Mouse monoclonal
anti-TGF-b antibody was from Genzyme (Cambridge, MA, USA).
Monoclonal anti-ERK-activated (P-ERK) and a-Smooth Muscle
Actin Immunohistology Kits were from Sigma (St Louis, MO, USA).
Anti-p38 (C-20) and anti-JNK (FL) antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Anti-ERK antibody
(Erk1/2-CT, rabbit polyclonal IgG) was from Upstate Biotechnology
(Lake Placid, NY, USA). Peroxidase-conjugated rabbit anti-mouse
and peroxidase-conjugated swine anti-rabbit immunoglobulins, and
DAKO Protein K Enzyme Digestion were from Dako A/S (Glostrup,
Denmark). ApopTag Peroxydase In situ Apoptosis Detection Kit was
from Intergen Company (Purchase, NY, USA).
Immunohistochemistry
Immunohistochemical staining was performed on serial sections
4 mm thick, using enzyme-labeled antibody method. Paraffin
sections were deparaffinized and rehydrated. Endogenous peroxide
activity was quenched by incubating sections in 0.3% H2O2/
methanol for 30 min. To unmask antigens, slides were boiled at
100 1C for 10 min in 10% citrate buffer (pH 6.0)/methanol or
40 min in 1 mM EDTA (pH 8.0). Sections were incubated with
antibodies against CD10 (1:1), Pax2 (1:30), Ki-67 (1:20), TGF-b
(100 mg ml1), aSMA (1:1), p38 (1:200), JNK (1:200), P-ERK
(1:100), and ERK (1:100) at 4 1C overnight. After incubating with
a secondary antibody at a concentration of 1:100, immunoreaction
products were developed using 3,30-diaminobenzidine as the
chromogen, with standardized development times. Sections were
then counterstained with methyl green. The primary antibody was
omitted from the staining procedure in negative controls.
Detection of apoptosis
Cells undergoing apoptosis were identified using an in situ DNA
labeling method. Paraffin-embedded sections were deparaffinized,
and TUNEL staining was performed using the ApopTag kit. Sections
were counterstained with methyl green. TdT was omitted from the
staining procedure in negative controls.
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